Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre
G. Spoletini (Leeds, United Kingdom), R. Watson (Leeds, United Kingdom), K. Pollard (Leeds, United Kingdom), C. Etherington (Leeds, United Kingdom), I. Clifton (Leeds, United Kingdom), P. Whitaker (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom)
Source: International Congress 2019 – Physiology of cystic fibrosis
Session: Physiology of cystic fibrosis
Session type: Poster Discussion
Number: 337
Disease area: -
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Spoletini (Leeds, United Kingdom), R. Watson (Leeds, United Kingdom), K. Pollard (Leeds, United Kingdom), C. Etherington (Leeds, United Kingdom), I. Clifton (Leeds, United Kingdom), P. Whitaker (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom). Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre. 337
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: